IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer
The EMBO Journal · 2023
DOI: 10.15252/embj.2022110620 ↗Kurz gefasst
Fachartikel in der Zeitschrift The EMBO Journal, 2023. Verfasst von Keisuke Shigeta und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Carcinoma, Transitional Cell, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Grant‐in‐Aid for Scientific Research of Japan, Japanese Foundation for Research and Promotion of Endoscopy Grant, Keio Medical Association Grant.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Keio University School of Medicine, Tokyo, Japan.
- Department of Urology, Tokai University School of Medicine, Tokyo, Japan.
- Department of Clinical and Translational Research center, Keio University School of Medicine, Tokyo, Japan.
- Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan.
- Division of Pathology, Keio University School of Medicine, Tokyo, Japan.
- Department of Urology, St. Marianna University School of Medicine, Kanagawa, Japan.
ORCID-Profile: Keisuke Shigeta, Masanori Hasegawa, Takeo Kosaka, Mototsugu Oya
Förderung
- Grant‐in‐Aid for Scientific Research of Japan
- Japanese Foundation for Research and Promotion of Endoscopy Grant
- Keio Medical Association Grant
- Keio Medical Otsuka Fumon/Fusako Fellowship Grant
- Keio University Graduate School Doctoral Program Grant
Zitieren
APA
Shigeta, K., Hasegawa, M., Hishiki, T., Naito, Y., Baba, Y., Mikami, S., Matsumoto, K., Mizuno, R., Miyajima, A., Kikuchi, E., Saya, H., Kosaka, T., & Oya, M. (2023). IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. The EMBO Journal. https://doi.org/10.15252/embj.2022110620
Vancouver
Shigeta K, Hasegawa M, Hishiki T, Naito Y, Baba Y, Mikami S, et al. IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. The EMBO Journal. 2023. doi:10.15252/embj.2022110620
BibTeX
@article{Shigeta2023,
author = {Shigeta, Keisuke and Hasegawa, Masanori and Hishiki, Takako and Naito, Yoshiko and Baba, Yuto and Mikami, Shuji and Matsumoto, Kazuhiro and Mizuno, Ryuichi and Miyajima, Akira and Kikuchi, Eiji and Saya, Hideyuki and Kosaka, Takeo and Oya, Mototsugu},
title = {IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer},
journal = {The EMBO Journal},
year = {2023},
doi = {10.15252/embj.2022110620}
}
EUVIMED